Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 4-Week, Double-Blind, Randomized, Multicenter, Fixed Dose, Placebo-Controlled, Parallel Group Study of Lorazepam and Paroxetine in Patients With Generalized Anxiety Disorder: Assessment of a New Instrument Intended to Capture Rapid Onset

NCT00715039 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00715039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00715039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 4-Week, Double-Blind, Randomized, Multicenter, Fixed Dose, Placebo-Controlled, Parallel Group Study of Lorazepam and Paroxetine in Patients With Generalized Anxiety Disorder: Assessment of a New Instrument Intended to Capture Rapid Onset
Lead sponsor
Pfizer
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2003
Completion date
May 31, 2004
Enrollment
169 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders